Advertisement

Topics

New patent expiration for Boehringer Ingelheim drug JENTADUETO

00:06 EST 2 Feb 2019 | BiotechBlog

Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from two suppliers. There are fifteen patents…
The post New patent expiration for Boehringer Ingelheim drug...

The post New patent expiration for Boehringer Ingelheim drug JENTADUETO appeared first on Biotechblog.

Original Article: New patent expiration for Boehringer Ingelheim drug JENTADUETO

NEXT ARTICLE

More From BioPortfolio on "New patent expiration for Boehringer Ingelheim drug JENTADUETO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...